Deprescribing & Polypharmacy at Psych Congress 2026
3 sessions on deprescribing & polypharmacy · September 15–19, 2026, New Orleans, LA. Compare deprescribing & polypharmacy at other meetings →
Wednesday, September 16
Lecture · Bipolar Disorders
Complex Psychopharmacology in Bipolar Disorder: Combination Therapy, Dosing Pearls & Side-Effect Navigation
Advanced guidance on sequencing lithium, anticonvulsants, and atypical antipsychotics in bipolar disorder, with case vignettes on inadequate response, intolerability, and polypharmacy.
Antipsychotic Prescribing · Bipolar Disorder · Lithium & Mood Stabilizers
Symposium · Bipolar Disorders
Deprescribing Definitions and Decisions Differ by Diagnosis: A Deep Dive for Bipolar & Schizophrenia Disorders
Joseph Goldberg · Peter Weiden
Compares how polypharmacy patterns and risk-benefit calculations shape deprescribing decisions differently in bipolar disorder versus schizophrenia.
Saturday, September 19
Plenary · Closing Session
Cultivating Clinical Wisdom in Deprescribing - Practical Considerations for Psychiatry
Rakesh Jain · Saundra Jain · Arwen Podesta · Charles Raison
Closing session on when and how to reduce psychotropic regimens: identifying candidates, shared decision-making, and safe tapering while weighing relapse and withdrawal risks.
Other topics at this meeting
Depression 10Neuroscience & Mechanisms 10Schizophrenia & Psychosis 9Measurement-Based Care & Diagnosis 8Drug Pipeline & Clinical Trials 7Sleep & Insomnia 7ADHD 6Bipolar Disorder 6Drug Interactions & Safety 6Lifestyle & Integrative Psychiatry 6Psychotherapy 6Antipsychotic Prescribing 5